Technical Analysis for DNAY - Codex DNA, Inc.

Grade Last Price % Change Price Change
D 15.32 -3.16% -0.50
DNAY closed down 3.16 percent on Wednesday, August 4, 2021, on 1.16 times normal volume.
Earnings due: Aug 10
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical DNAY trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish -1.10%
Outside Day Range Expansion -1.10%
Hot IPO Pullback Bullish Swing Setup -2.98%
Outside Day Range Expansion -2.98%
Wide Bands Range Expansion -2.98%
Hot IPO Pullback Bullish Swing Setup -1.79%
Narrow Range Bar Range Contraction -1.79%
NR7 Range Contraction -1.79%
Inside Day Range Contraction -1.79%
Wide Bands Range Expansion -1.79%
Older End-of-Day Signals for DNAY ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Previous Day's Low about 18 hours ago
Possible Inside Day about 19 hours ago
60 Minute Opening Range Breakdown about 21 hours ago
Down 5% about 23 hours ago
Down 3% about 23 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Codex DNA, Inc. Description

Codex DNA is a synthetic biology company focused on enabling researchers to rapidly, accurately and reproducibly build or “write” high-quality synthetic DNA and mRNA that is ready to use in many downstream synthetic biology enabled markets. Codex DNA’s synthetic biology solution addresses the bottlenecks across the multi-step process of building DNA and mRNA, as well as the significant limitations of existing solutions that prevent the rapid building of virtually error-free DNA and mRNA at a useable scale. A key part of Codex DNA’s solution is the BioXp™ system, an end-to-end automated workstation that fits on the benchtop and is broadly accessible due to its ease-of-use and hands-free automation. Codex DNA believes the BioXp™ system can democratize synthetic biology by simplifying the process of building DNA and mRNA, thereby accelerating the discovery, development and production of novel high-value products, including antibody-based biologics, mRNA-based vaccines and therapeutics and precision medicines.


Sector: Healthcare
Industry: Medical Devices
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Emerging Technologies Molecular Biology RNA Synthetic Biology Molecular Genetics Messenger RNA

Is DNAY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 25.7
52 Week Low 13.75
Average Volume 148,213
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 15.99
10-Day Moving Average 16.09
Average True Range 1.63
ADX 7.83
+DI 16.77
-DI 17.29
Chandelier Exit (Long, 3 ATRs) 14.84
Chandelier Exit (Short, 3 ATRs) 18.64
Upper Bollinger Bands 17.67
Lower Bollinger Band 14.31
Percent B (%b) 0.3
BandWidth 20.97
MACD Line -0.93
MACD Signal Line -1.02
MACD Histogram 0.0892
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.05
Resistance 3 (R3) 17.03 16.44 16.76
Resistance 2 (R2) 16.44 16.00 16.45 16.66
Resistance 1 (R1) 15.88 15.73 15.59 15.90 16.57
Pivot Point 15.29 15.29 15.14 15.30 15.29
Support 1 (S1) 14.73 14.85 14.44 14.75 14.07
Support 2 (S2) 14.14 14.58 14.15 13.98
Support 3 (S3) 13.58 14.14 13.88
Support 4 (S4) 13.60